References
- AndersonNOrenPOguraTDuloxetine enteric pelletsOfficial Gazette of the United States Patent and Trademark Office Patents199611851954
- BymasterFDreshfield-AhmadLThrelkeldPComparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes and other neuronal receptorsNeuropsychopharmacology2001258718011750180
- DiVirgilioSGonzalesCKnadlerMEffect of duloxetine (DU) on CYP1A2-mediated drug metabolism and the pharmacokinetics (PK) of theophylline (THEO)Clin Pharmacol Ther20027163
- GoldsteinDLuYDetkeMJDuloxetine vs. placebo in patients with painful diabetic neuropathyPain20051161091815927394
- HokeAFeasbyTHumesHDisorders of the peripheral nervous systemKelley’s Textbook of Internal Medicine2000PhiladelphiaLippincott Williams and Wilkins29801
- IyengarSWebsterAHemrick-LueckeSEfficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in ratsJPET200431157684
- KuoFGillespieTKulanthaivelPSynthesis and biological activity of some known and putative duloxetine metabolitesBioorg Med Chem Lett2004143481615177457
- LantzRGillespieTRashTMetabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjectsDrug Metab Dispos20033111425012920170
- LynchMAntidepressants as analgesics: a review of randomized controlled trialsJ Psychiatry Neurosci20012630611212591
- RaskinJPritchettYLWangFA double-blind, randomized mutlicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Med200563465616266355
- RaskinJSmithTRWongKDuloxetine versus routine care in the long-term management of diabetic peripheral neuropathic painJ Palliat Med20069294016430342
- SathirakulKTengLYeoKImpact of gastric pH and the presence of activated charcoal on the absorption of duloxetineInt J Clin Pharmacol20027118
- SkinnerMKuanHPanADuloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersClin Pharmacol Ther200373170712621382
- SkinnerMWeerakkodyGDuloxetine does not exacerbate the effects of alcohol on psychometric testsClin Pharmacol Ther20027153
- Eli Lilly and CompanyCymbalta (duloxetine) package insert [online]2007 Accessed March 1, 2007. URL: http://pi.lilly.com/us/cymbalta-pi.pdf
- WadaRYagihashiSRole of advanced glycation end products and their receptors in development of diabetic neuropathyAnn N Y Acad Sci2005104359860416037282
- WernickeJFPritchettYLD’SousaDNA randomized controlled trial of duloxetine in diabetic peripheral neuropathic painNeurology2006a6714112017060567
- WernickeJFRaskinJRosenADuloxetine in long-term management of diabetic peripheral neuropathic pain: an open-label, 52 week extension of a randomized controlled clinical trialCurr Ther Res Clin Exp2006b67283304
- WernickeJFWangFPritchettYLAn open-label 52 week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic painPain MedfIn press
- WongDBymasterFDual serotonin and noradrenalin reuptake inhibitor class of anti-depressants: potential for greater efficacy or just hype?Prog Drug Res20025816922212079200
- WongDBymasterFMayleDLY248686, a new inhibitor of serotonin and norepinephrine uptakeNeuropsychopharmacology1993823338424846
- WoolfCMannionRNeuropathic pain: aetiology, symptoms, mechanisms and managementLancet199935319596410371588
- YakshTPharmacology of spinal adrenergic systems which modulate spinal nociceptive processingPharmacol Biochem Behav198522845582861606
- ZhouMGebhartGBiphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the ratJ Neurophysiol199778746589307109